Heska Corporation is a diagnostics & research business based in the US. Heska Corporation shares (HSKA) are listed on the NASDAQ and all prices are listed in US Dollars. Heska Corporation employs 602 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Heska Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HSKA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- HSKA shares summary
- Compare share dealing platforms
- Is HSKA stock a buy or sell?
- Stock performance over time
- Can I short HSKA shares?
- Are HSKA shares over-valued?
- Heska Corporation's financials
- How volatile are HSKA shares?
- Does Heska Corporation pay a dividend?
- Have HSKA shares ever split?
- Other common questions
Heska Corporation stock price (NASDAQ: HSKA)Use our graph to track the performance of HSKA stocks over time.
Heska Corporation shares at a glance
|Latest market close||$198.15|
|52-week range||$87.62 - $255.75|
|50-day moving average||$233.15|
|200-day moving average||$195.67|
|Wall St. target price||$233.40|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.47|
Buy Heska Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Heska Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Heska Corporation price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-16.04%|
|3 months (2021-04-30)||8.49%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Is Heska Corporation under- or over-valued?
Valuing Heska Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Heska Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Heska Corporation's PEG ratio
Heska Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Heska Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Heska Corporation's EBITDA
Heska Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15.1 million.
The EBITDA is a measure of a Heska Corporation's overall financial performance and is widely used to measure a its profitability.
Heska Corporation financials
|Revenue TTM||$227.2 million|
|Operating margin TTM||1.42%|
|Gross profit TTM||$81.3 million|
|Return on assets TTM||0.44%|
|Return on equity TTM||-2.14%|
|Market capitalisation||$2.6 billion|
TTM: trailing 12 months
Shorting Heska Corporation shares
There are currently 390,129 Heska Corporation shares held short by investors – that's known as Heska Corporation's "short interest". This figure is 10.5% down from 436,014 last month.
There are a few different ways that this level of interest in shorting Heska Corporation shares can be evaluated.
Heska Corporation's "short interest ratio" (SIR)
Heska Corporation's "short interest ratio" (SIR) is the quantity of Heska Corporation shares currently shorted divided by the average quantity of Heska Corporation shares traded daily (recently around 89479.128440367). Heska Corporation's SIR currently stands at 4.36. In other words for every 100,000 Heska Corporation shares traded daily on the market, roughly 4360 shares are currently held short.
However Heska Corporation's short interest can also be evaluated against the total number of Heska Corporation shares, or, against the total number of tradable Heska Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Heska Corporation's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Heska Corporation shares in existence, roughly 40 shares are currently held short) or 0.0432% of the tradable shares (for every 100,000 tradable Heska Corporation shares, roughly 43 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Heska Corporation.
Find out more about how you can short Heska Corporation stock.
Heska Corporation share dividends
We're not expecting Heska Corporation to pay a dividend over the next 12 months.
Have Heska Corporation's shares ever split?
Heska Corporation's shares were split on a 1:10 basis on 29 December 2010. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heska Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Heska Corporation shares which in turn could have impacted Heska Corporation's share price.
Heska Corporation share price volatility
Over the last 12 months, Heska Corporation's shares have ranged in value from as little as $87.62 up to $255.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Heska Corporation's is 1.6904. This would suggest that Heska Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Heska Corporation overview
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Additionally, the company provides a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. It sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995.
Stocks similar to Heska Corporation
Heska Corporation in the news
What Does Heska Corporation's (NASDAQ:HSKA) Share Price Indicate?
Stocks That Hit 52-Week Highs On Tuesday
If You Had Bought Heska (NASDAQ:HSKA) Shares Five Years Ago You'd Have Earned 464% Returns
Frequently asked questionsWhat percentage of Heska Corporation is owned by insiders or institutions?
Currently 5.74% of Heska Corporation shares are held by insiders and 98.384% by institutions. How many people work for Heska Corporation?
Latest data suggests 602 work at Heska Corporation. When does the fiscal year end for Heska Corporation?
Heska Corporation's fiscal year ends in December. Where is Heska Corporation based?
Heska Corporation's address is: 3760 Rocky Mountain Avenue, Loveland, CO, United States, 80538 What is Heska Corporation's ISIN number?
Heska Corporation's international securities identification number is: US42805E3062 What is Heska Corporation's CUSIP number?
Heska Corporation's Committee on Uniform Securities Identification Procedures number is: 42805E108
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert